Grow Funds highlighted Buda Juice in its first-quarter 2026 investor letter, projecting the stock could reach $25 as the company scales within Texas. Buda Juice, which produces organic cold-pressed juices and wellness shots sold in supermarkets like Costco, HEB, and Kroger, generated about $12 million in annual revenue and $3.6 million in net income last year. The firm noted that Buda Juice is expanding its Texas production capacity to $55 million by adding lines, and anticipates additional facilities in the Southeast and Southwest U.S. within two years, potentially supporting up to $165 million in annual revenue. The stock closed at $8.01 on June 22, 2026, with a market capitalization of $100.66 million.
Buda Juice, Inc.Grow Funds projects stock reaching $25 based on Texas expansion and revenue potential.